Stocks and Investing
Stocks and Investing
Thu, January 23, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, January 22, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Eliana Merle Downgraded (BNTX) to Hold and Increased Target to $35 on, Jan 22nd, 2020
Eliana Merle of UBS, Downgraded "BioNTech SE" (BNTX) to Hold and Increased Target from $21 to $35 on, Jan 22nd, 2020.
Eliana has made no other calls on BNTX in the last 4 months.
There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 0 agree with Eliana's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Eliana
- Cory Kasimov of "JP Morgan" Initiated at Buy and Held Target at $23 on, Monday, November 4th, 2019
- Daina Graybosch of "SVB Leerink" Initiated at Buy on, Monday, November 4th, 2019
- Tazeen Ahmad of "B of A Securities" Initiated at Strong Buy and Held Target at $21 on, Monday, November 4th, 2019
Contributing Sources